Barrier Recovery Gel Cream Base

1. INCI & CAS

INCI: Ceramide NP · CAS: 100403-19-8

2. Role in the formula

Ceramide NP is listed as a ceramide lipid in this development reference. The recorded formula also lists Ceramide AP and Ceramide EOP. Review the lipid combination in the complete formula; ingredient presence alone does not establish barrier performance.

3. Typical use levels (formulation guide)

• A component allocation of 0.2% w/w is listed as guidance.

Usually introduced via a pre-dispersed lipid concentrate or warm oil/lamellar phase; avoid prolonged high-heat holds after ceramides are fully melted.

4. Regulatory sources & global compliance

• Read this as formulation guidance for development; it is not approval of the purchased material or completed cosmetic; No product-specific approval is provided here.

5. Safety & risk assessment

Generally used at low percentages in leave-on cosmetics. Finished-product irritation and sensitization checks remain required; no drug or wound-healing claims.

6. Stability & packaging

Protect from unnecessary oxidation and extreme pH. Prefer opaque or UV-protective packs for premium barrier gel-creams; verify pump/airless compatibility.

7. Claims language (Do / Don’t)

• Helps support a comforted, barrier-looking skin feel
• Supports a calm, cushioned finish in leave-on formulas

• Do not claim clinical barrier repair as a drug outcome
• Do not imply regulatory endorsement by CosIng/IECIC listings alone

1. INCI & CAS

INCI: Cholesterol · CAS: 57-88-5

2. Role in the formula

Cholesterol is listed as a lipid component in this development reference. The recorded formula also lists Ceramide NP and Ceramide AP. Review its place in the recorded lipid combination and evaluate the complete formula.

3. Typical use levels (formulation guide)

• A component allocation of 0.2% w/w is listed as guidance.

Melt with the ceramide/oil phase; cool under controlled shear to encourage lamellar order.

4. Regulatory sources & global compliance

• This formulation note is a guide for development; it does not certify the supplied material or completed cosmetic; The note should not be read as approval of the final formula.

5. Safety & risk assessment

Widely used in leave-on cosmetics at guide levels. Confirm finished-product tolerance for sensitive-skin positioning.

6. Stability & packaging

Store cool and dry in bulk. In pack, protect from prolonged heat and light; airless or pump packs preferred.

7. Claims language (Do / Don’t)

• Helps support a comfortable, barrier-oriented skin feel
• Supports a refined lipid finish in leave-on formulas

• Do not claim medical cholesterol therapy or disease treatment

1. INCI & CAS

INCI: Madecassoside · CAS: 34540-22-2

2. Role in the formula

Madecassoside is listed as a Centella-associated glycoside in this development reference. The recorded formula also lists Ceramide NP and Ceramide AP. Review this ingredient within the recorded combination; finished-formula comfort claims require supporting evidence.

3. Typical use levels (formulation guide)

• The guide level assigned to this component is 0.2% w/w.

Dissolve in the water phase or approved solvent; avoid unnecessary high-heat holds after addition.

4. Regulatory sources & global compliance

• This record describes a development reference; it offers no approval of the ingredient grade or finished product; No authorization for the final cosmetic is implied.

5. Safety & risk assessment

Used in cosmetics as a purified active at low percentages. Finished-product safety assessment still required; avoid therapeutic claims.

6. Stability & packaging

Keep sealed, cool and dry in storage. In formula, protect from extreme pH swings and prolonged UV; opaque airless or pump packs preferred.

7. Claims language (Do / Don’t)

• Helps support a comforted, recovered-looking skin feel
• Premium Centella marker for barrier-recovery formulas

• Do not claim clinical cure, anti-inflammatory drug action or hospital-grade repair